Mobile App

Google Play Apple Store
Lightning Reports™ from ASCO 2022: Targeted Therapy in Lung Cancer
Certified AMA/ANCC/ACPE - Lightning Reports
Lightning Reports are accredited, on-demand video presentations that feature experts discussing recent clinical updates, hot topics and treatment options. These activities are designed to keep healthcare professionals on top of the most recent clinical findings.

This series of certified AMA/ANCC/ACPE enduring videos will spotlight the latest advances in the management of lung cancer treated with targeted therapy through a series of ‘what you need to know’ videos featuring a leading expert reporting from the 2022 ASCO Annual Meeting.
Review the video(s) to claim AMA/ANCC/ACPE credit after completion of the brief Post-Test/Evaluation(s).
Mark A. Socinski, MD
Mark A. Socinski, MD
Executive Medical Director
AdventHealth Cancer Institute







*This coverage is not sanctioned by the conference organizers and is not an official part of the conference proceedings of the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting.
20

Supported by independent educational grants from AstraZeneca and Genentech, a member of the Roche Group


Launch Date: June 6, 2022

Release Date: June 6, 2022

Expiration Date: May 31, 2023

May 31, 2023
Mini Module
7405
LighteningReports.Lung_WebBanner(1150).gif
Hematology-Oncology